RedHill Biopharma Ltd (RDHL): $RDHL RedHill Biopharma https://fina...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	145
Posts	27727
Boards Moderated	3
Alias Born	02/07/2004

midastouch017

Re: None

Wednesday, 08/21/2024 11:34:17 AM

Wednesday, August 21, 2024 11:34:17 AM

$RDHL RedHill Biopharma

https://finance.yahoo.com/news/three-undiscovered-gems-united-states-150814759.html

Overview: RedHill Biopharma Ltd. is a specialty biopharmaceutical company that primarily focuses on gastrointestinal and infectious diseases, with a market cap of $256.99 million.

Operations: RedHill Biopharma Ltd. derives its revenue from the sale of specialty biopharmaceutical products targeting gastrointestinal and infectious diseases. The company has a market cap of $256.99 million.

RedHill Biopharma, a small cap stock, recently reported a significant one-off gain of US$54.6M for the year ending December 31, 2023. The company is debt-free and has maintained this status for over five years. Despite becoming profitable last year, its share price has been highly volatile over the past three months. Recent developments include the launch of Talicia in the UAE and positive results from studies on opaganib for Type 2 diabetes treatment.